Breaking news & key AI updates in healthcare, medicine & pharma/biotech
The Melbourne company splits $340M of new capital between a Series C and revenue-based growth financing.
St. Luke's Boise data governance chief warns hospitals that AI cannot fix poor data quality…
HHS commits NIH resources to Trump's $5B Genesis Mission, targeting chronic disease, pediatric cancer, and…
BMS is building dedicated AI compute infrastructure with Nvidia to accelerate molecular modeling and drug…
Tempus AI adds Personalis' liquid biopsy and tumor sequencing capabilities in a $1.5 billion acquisition.
MD Anderson researchers develop AI-guided technique to map brain tumor blood supply, enabling more precise…